|
|
Ribamune (Ribavirin)
What is Ribamune (Ribavirin) used for? Ribamune (Ribavirin) is treatment for patients with chronic hepatitis who have not been treated with an interferon in the past. It is an antiviral medication of the nucleoside analogue class. It is always prescribed as part of a full treatment plan for people with chronic hepatitis C, usually in combination therapy with peginterferon. Ribavirin is a nucleoside analogue type of antiviral medicine. It works by preventing the further spreading in the body of the virus that causes hepatitis C. How should I use Ribamune (Ribavirin)? Ribavirin capsules are usually prescribed at a dosage that will be taken twice daily (usually with the morning and evening meal). In general, the other drugs that make up your treatment plan will be taken at the same time. Swallow each capsule of Ribavirin whole with a glass of water. Your doctor will have prescribed you a specific dose of each medicine. Take only the dosages that has been prescribed, and follow any instructions they have given you. Ribavirin must not be taken on its own. It should always be prescribed as part of a complete treatment plan including another drug - usually peginterferon. Your doctor will prescribe a full treatment plan for you. What are the side effects of Ribamune (Ribavirin)? Ribamune (Ribavirin) and peginterferon can cause some unwanted side effects. Some are common and should pass over time, while others should be treated as more threatening. Common side effects associated with Ribamune (Ribavirin) are listed below. These are not a cause for concern unless the worsen or do not subside over time.
The list below contains some more serious side effects associated with Ribavirin. Tell your doctor immediately if you notice any of these:
Please Note Ribavirin may not be suitable for all people. Make your you doctor is fully aware of your medical history. Ribavirin should not be used by pregnant women or women who are trying to become pregnant. It may also not be safe for women who are breastfeeding. |